Article Details

XBiotech (XBIT) Stock Falls After Receiving FDA Approval for Pancreatic Cancer Drug Trials

Retrieved on: 2021-04-19 16:07:30

Tags for this article:

Click the tags to see associated articles and topics

XBiotech (XBIT) Stock Falls After Receiving FDA Approval for Pancreatic Cancer Drug Trials. View article details on hiswai:

Excerpt

It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company ...

Article found on: www.investorsobserver.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up